Filtros de búsqueda

Lista de obras de Bruno Vincenzi

'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer

artículo científico publicado en 2013

'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine

artículo científico publicado en 2009

'Old' and 'new' drugs for the treatment of cancer pain

artículo científico

A giant sarcoma of the parotid gland: a case report and review of the literature.

artículo científico publicado en 2006

A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss

artículo científico publicado en 2006

A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study

artículo científico publicado en 2005

A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.

artículo científico publicado en 2010

A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients

artículo científico publicado en 2006

A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients

artículo científico publicado en 2012

A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid

artículo científico publicado en 2007

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

artículo científico publicado en 2017

Adjuvant electrochemotherapy for the treatment of incompletely excised spontaneous canine sarcomas

artículo científico publicado en 2007

Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors

scientific article published on 01 November 2006

An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer

artículo científico publicado en 2006

Analysis of Fas (Apo-1/CD95) expression in non-small cell lung cancer.

artículo científico publicado en 2003

Analysis of HtrA1 serine protease expression in human lung cancer.

artículo científico publicado en 2006

Anaphylaxis to dexrazoxane (ICRF-187) following three previous uncomplicated infusions

artículo científico publicado en 2004

Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients

artículo científico publicado en 2006

Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series

artículo científico publicado en 2018

Antiangiogenic properties of metronomic chemotherapy in breast cancer.

artículo científico publicado en 2007

Antiproliferative effect of Aurora kinase targeting in mesothelioma

artículo científico publicado en 2010

Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.

artículo científico publicado en 2006

Aprepitant against pruritus in patients with solid tumours

artículo científico publicado en 2010

Aprepitant for erlotinib-induced pruritus

artículo científico publicado en 2010

Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study.

artículo científico publicado en 2012

Are bisphosphonates the suitable anticancer drugs for the elderly?

artículo científico publicado en 2008

Aromatase inhibitor exemestane has antiproliferative effects on human mesothelioma cells

artículo científico publicado en 2011

Atypical chronic head and neck pain: don't forget Eagle's syndrome.

artículo científico publicado en 2008

Azygo-tracheal fistula in a complete implantable central venous system

artículo científico publicado en 2006

Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors

artículo científico publicado en 2007

Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial.

artículo científico publicado en 2009

Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect

artículo científico publicado en 2003

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.

artículo científico publicado en 2015

Biological interaction between anti-epidermal growth factor receptor agent cetuximab and magnesium

artículo científico publicado en 2008

Bisphosphonate anticancer activity.

artículo científico publicado en 2011

Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities.

artículo científico publicado en 2004

Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence

artículo científico publicado en 2015

Bisphosphonates: new antiangiogenic molecules in cancer treatment?

scientific article published on 01 May 2003

Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment.

artículo científico publicado en 2013

Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions

artículo científico publicado en 2007

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

artículo científico publicado en 2015

Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options

artículo científico publicado en 2013

CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients

artículo científico publicado en 2010

COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.

artículo científico

COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables.

artículo científico publicado en 2006

COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification

scientific article published on 01 June 2007

COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters

artículo científico publicado en 2006

Cancer chronotherapy: principles, applications, and perspectives

artículo científico publicado en 2003

Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.

artículo científico publicado en 2013

Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer

artículo científico publicado en 2005

Cetuximab in small bowel adenocarcinoma: a new friend?

artículo científico publicado en 2010

Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status.

artículo científico publicado en 2010

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

artículo científico publicado en 2012

Cetuximab: from bench to bedside.

scientific article published on February 2010

Cetuximab: from biology to the care of colorectal cancer patients

scientific article published on 01 October 2007

Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours

artículo científico publicado en 2006

Chemosensitivity profile assay of circulating cancer cells: prognostic and predictive value in epithelial tumors.

artículo científico publicado en 2010

Chemotherapy-induced steatohepatitis in colorectal cancer patients

artículo científico publicado en 2006

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

artículo científico publicado en 2006

Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.

artículo científico publicado en 2011

Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients.

artículo científico publicado en 2009

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan

artículo científico publicado en 2007

Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

artículo científico publicado en 2010

Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?

artículo científico publicado en 2013

Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal.

artículo científico publicado en 2011

Classic Kaposi Sarcoma: to treat or not to treat?

artículo científico publicado en 2015

Comment and reply on: Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens

artículo científico publicado en 2013

Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient

artículo científico publicado en 2004

Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life

artículo científico publicado en 2007

Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients.

artículo científico publicado en 2005

Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer.

artículo científico publicado en 2004

Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients

artículo científico publicado en 2005

Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells

artículo científico publicado en 2009

Definition of novel electrochemotherapy parameters and validation of their in vitro and in vivo effectiveness

artículo científico publicado en 2014

Denosumab: the era of targeted therapies in bone metastatic diseases

artículo científico publicado en 2009

Deregulation of dicer and mir-155 expression in liposarcoma.

artículo científico publicado en 2015

Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients.

artículo científico publicado en 2012

Docetaxel induced pericardial effusion.

artículo científico publicado en 2007

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tiss

artículo científico publicado en 2020

Dramatic improvement of psoriasis with gemcitabine monotherapy

artículo científico publicado en 2003

Drug-induced hepatotoxicity in cancer patients - implication for treatment

artículo científico publicado en 2016

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients

artículo científico publicado en 2010

Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome

artículo científico publicado en 2008

Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib

artículo científico publicado en 2010

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

artículo científico publicado en 2010

Electrochemotherapy for the treatment of squamous cell carcinoma in cats: A preliminary report

artículo científico publicado en 2007

Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: an approach to improve the therapeutic index of highly toxic chemotherapy drugs

artículo científico

Electroporation Enhances Bleomycin Efficacy in Cats with Periocular Carcinoma and Advanced Squamous Cell Carcinoma of the Head

artículo científico publicado en 2015

Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo).

artículo científico publicado en 2012

Electroporation as a strategy to promote HtrA1 gene uptake and chemotherapy efficacy in a mouse model of mesothelioma

artículo científico publicado en 2013

Emerging anti-cancer molecular mechanisms of aminobisphosphonates

artículo científico publicado en 2006

Emerging drugs for the treatment of bone metastasis.

artículo científico

Emerging kinase inhibitors of the treatment of gastric cancer

artículo científico

Emerging therapeutic targets in osteoncology

artículo científico publicado en 2011

Endocrine disruptors in utero cause ovarian damages linked to endometriosis

artículo científico publicado en 2012

Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients (Br J Surg 2003; 90: 547-548).

artículo científico publicado en 2003

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients

artículo científico publicado en 2011

Erratum to: A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma

scholarly article published in Journal of Neuro-Oncology

European Society for Medical Oncology 2006: meeting highlights on targeted therapies. Istanbul, Turkey, 29 September-3 October 2006

artículo científico publicado en 2007

Evaluation of Cisplatin as an Electrochemotherapy Agent for the Treatment of Incompletely Excised Mast Cell Tumors in Dogs

artículo científico publicado en 2011

Evidence-based guidelines: Improving AGREEment on consistence evaluation

artículo científico publicado en 2012

Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma

artículo científico publicado en 2012

Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival

artículo científico publicado en 2002

Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases

artículo científico publicado en 2011

Fatal thrombocytopenia and thrombocytopathia: an unusual onset of non-small cell lung cancer.

artículo científico publicado en 2003

Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6.

artículo científico publicado en 2003

Fibronectin and laminin expression in sentinel lymph nodes of patients with malignant melanoma

scientific article published on 15 June 2007

First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab

artículo científico publicado en 2009

Gastrointestinal stromal tumors: a new model for target therapy

artículo científico publicado en 2003

Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study

artículo científico publicado en 2002

Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network

article

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

artículo científico publicado en 2010

Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis

artículo científico publicado en 2009

Gemcitabine-induced atrial fibrillation: a hitherto unreported manifestation of drug toxicity

artículo científico publicado en 2000

Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan

artículo científico publicado en 2010

Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.

artículo científico publicado en 2014

Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target

artículo científico publicado en 2009

HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells

artículo científico publicado en 2011

High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice

artículo científico publicado en 2010

High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice

artículo científico publicado en 2008

High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors

artículo científico publicado en 2014

High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease

artículo científico publicado en 2012

Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions

scientific article published on 01 February 2008

Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy.

artículo científico publicado en 2010

Hot topic: biology in anticancer treatment

artículo científico publicado en 2010

HtrA1 loss is related to aggressive behavior parameters in sentinel node positive breast cancer

artículo científico publicado en 2014

Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC).

artículo científico publicado en 2011

Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer

artículo científico publicado en 2008

Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes.

artículo científico publicado en 2010

Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.

artículo científico publicado en 2012

Idiosyncratic reaction after oxaliplatin infusion

artículo científico publicado en 2001

Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis

artículo científico publicado en 2015

Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey

artículo científico publicado en 2014

In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients

artículo científico publicado en 2008

Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.

artículo científico publicado en 2014

Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated

artículo científico publicado en 2013

Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis

artículo científico publicado en 2008

Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: a preliminary study in a spontaneous feline model

artículo científico publicado en 2006

Italian translation of the Manchester-Oxford Foot Questionnaire, with re-assessment of reliability and validity

artículo científico publicado en 2009

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

artículo científico publicado en 2009

Lack of Correlation Between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: a Retrospective Study

artículo científico publicado en 2015

Lack of response of cetuximab plus oxaliplatin in advanced colorectal cancer patients resistant to both oxaliplatin and cetuximab plus irinotecan

artículo científico publicado en 2005

Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?

artículo científico publicado en 2006

Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor.

artículo científico publicado en 2002

Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality

artículo científico publicado en 2004

Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience

artículo científico publicado en 2015

Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients

artículo científico publicado en 2009

MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients

artículo científico publicado en 2009

Magnesium: are we better off without it?

artículo científico publicado en 2013

Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report.

artículo científico publicado en 2007

Mechanisms of disease: Preclinical reports of antineoplastic synergistic action of bisphosphonates

artículo científico publicado en 2006

Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancer

artículo científico publicado en 2009

Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study

artículo científico publicado en 2014

MicroRNAs and bone metastasis: a new challenge.

artículo científico publicado en 2014

Molecular prognostic factors in patients with pancreatic cancer.

artículo científico publicado en 2007

Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma

artículo científico publicado en 2007

NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population.

artículo científico publicado en 2009

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

artículo científico publicado en 2015

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study

artículo científico publicado en 2012

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

artículo científico publicado en 2013

Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging.

artículo científico publicado en 2004

Neuroendocrine tumor presenting like lymphoma: a case report

artículo científico publicado en 2011

Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial

scientific article published on 06 February 2020

New developments of aminobisphosphonates: the double face of Janus.

artículo científico publicado en 2007

New drugs for chemotherapy-induced nausea and vomiting: focus on palonosetron.

artículo científico publicado en 2005

New issues on cetuximab mechanism of action in epidermal growth factor receptor-negative colorectal cancer: the role of vascular endothelial growth factor

artículo científico publicado en 2006

New molecular targets in bone metastases.

artículo científico publicado en 2010

New perspectives: role of Sunitinib in breast cancer.

artículo científico publicado en 2011

New perspectives: role of sunitinib in breast cancer.

artículo científico publicado en 2010

New target agents in the treatment of colorectal cancer patients

artículo científico publicado en 2007

New targets, new drugs for metastatic bone pain: a new philosophy.

artículo científico publicado en 2011

New therapies in soft tissue sarcoma.

scientific article published on June 2010

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.

artículo científico publicado en 2005

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.

artículo científico publicado en 2005

Occasional FDG PET recognition of in situ breast cancer.

artículo científico publicado en 2007

Ocular toxicity related to cetuximab monotherapy in an advanced colorectal cancer patient

artículo científico publicado en 2005

Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients

artículo científico publicado en 2002

Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR.

artículo científico publicado en 2011

PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients

artículo científico publicado en 2012

PML down-regulation in soft tissue sarcomas

artículo científico publicado en 2010

PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy

artículo científico publicado en 2012

Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer

artículo científico publicado en 2005

Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

artículo científico publicado en 2002

Papillary pneumocytoma of the lung simulating a pleomorphic adenoma

artículo científico publicado en 2002

Paraneoplastic syndromes: what we know and what we should know

artículo científico publicado en 2006

Patterns of tumor response in canine and feline cancer patients treated with electrochemotherapy: preclinical data for the standardization of this treatment in pets and humans

artículo científico publicado en 2007

Pazopanib and pancreatic toxicity: a case report.

artículo científico publicado en 2015

Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy

artículo científico publicado en 2006

Pharmacogenomics of cetuximab in metastatic colorectal carcinoma.

artículo científico publicado en 2014

Phase I clinical and pharmacokinetic study of BBR 3576, a novel aza-anthrapyrazole, administered i.v. every 4 weeks in patients with advanced solid tumors: a phase I study group trial of the Central European Society of Anticancer-Drug Research (CESA

artículo científico publicado en 2004

Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer

artículo científico publicado en 2006

Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma

artículo científico publicado en 2006

Potential role of everolimus in inducing cholestasis

artículo científico publicado en 2009

Pre-natal exposure of mice to bisphenol A elicits an endometriosis-like phenotype in female offspring

artículo científico publicado en 2010

Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer.

artículo científico publicado en 2008

Predictive factors for response to chemotherapy in colorectal cancer patients

artículo científico publicado en 2004

Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence.

artículo científico publicado en 2011

Predictors of benefit in colorectal cancer treated with cetuximab: are we getting "Lost in TranslationAL"?

artículo científico publicado en 2010

Premetastatic niche: ready for new therapeutic interventions?

artículo científico publicado en 2012

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study ⬇️

artículo científico

Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis: a pilot study with ACTH-Depot plus tropisetron.

artículo científico publicado en 2001

Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.

artículo científico publicado en 2011

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

artículo científico publicado en 2015

Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer

artículo científico publicado en 2004

Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.

artículo científico publicado en 2010

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.

artículo científico publicado en 2015

Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma

artículo científico publicado en 2004

Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer.

artículo científico publicado en 2010

Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.

artículo científico publicado en 2005

Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis

artículo científico publicado en 2012

Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases

artículo científico publicado en 2012

Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma

artículo científico publicado en 2006

Raltitrexed as monochemotherapy induces a statistically significant increase in platelet count

artículo científico publicado en 2002

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase ii study.

artículo científico publicado en 2004

Raltitrexed-induced hepatotoxicity: multivariate analysis of predictive factors

artículo científico publicado en 2003

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance

artículo científico publicado en 2009

Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients

artículo científico publicado en 2011

Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer.

artículo científico publicado en 2013

Recurrent episodes of involuntary masticatory spasms induced by continuous infusion of oxaliplatin

artículo científico publicado en 2003

Recurrent thrombophlebitis in a colon cancer patient with C677T heterozygous genotype for MTHFR treated with 5-fluorouracil-based adjuvant chemotherapy

artículo científico publicado en 2004

Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade.

artículo científico publicado en 2007

Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients

artículo científico publicado en 2007

Response to chemotherapy of solitary fibrous tumour: A retrospective study

scientific article published on 06 April 2013

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

artículo científico publicado en 2011

Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials

artículo científico

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

artículo científico publicado en 2016

Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients

artículo científico publicado en 2011

Role of c-mesenchymal-epithelial transition pathway in gastric cancer.

artículo científico

S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury.

artículo científico publicado en 2003

Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: it is not about the destination, it is about the journey

artículo científico publicado en 2013

Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study

scientific article published on 12 January 2012

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw.

artículo científico publicado en 2012

Serum lactate dehydrogenase alone is not a helpful prognostic factor in resected colorectal cancer patients

artículo científico publicado en 2014

Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient

artículo científico publicado en 2003

Short-term effectiveness of smoking-cessation treatment on respiratory function and CEA level.

artículo científico publicado en 2013

Should oncologists be aware in their clinical practice of KRAS molecular analysis?

artículo científico publicado en 2011

Skin Lesions in Melanoma and Kaposi’s Sarcoma

artículo científico publicado en 2002

Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience

artículo científico publicado en 2012

Sorafenib in elderly patients with advanced hepatocellular carcinoma: a case series

artículo científico publicado en 2013

Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study

artículo científico publicado en 2009

Statins may potentiate bisphosphonates anticancer properties: a new pharmacological approach?

artículo científico publicado en 2003

Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab.

artículo científico publicado en 2009

Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?

artículo científico publicado en 2013

Surgery and electrochemotherapy of a high-grade soft tissue sarcoma in a dog

artículo científico publicado en 2008

Surgical complications after resection of adrenal carcinoma

artículo científico publicado en 2006

Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy.

artículo científico publicado en 2008

Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network

scientific article published on 19 September 2019

Target therapy in gastrointestinal tract sarcoma: What is new?

artículo científico publicado en 2010

Targeted therapy in biliary tract cancer: 2009 update.

scientific article published on December 2009

Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside.

artículo científico publicado en 2011

Targeting EGFR in bilio-pancreatic and liver carcinoma

artículo científico publicado en 2011

Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence.

artículo científico publicado en 2007

Targeting bone metastases starting from the preneoplastic niche: home sweet home

artículo científico publicado en 2011

Taxanes in adjuvant chemotherapy for early breast cancer

artículo científico publicado en 2006

The antineoplastic role of bisphosphonates: from basic research to clinical evidence.

artículo científico publicado en 2003

The antineoplastic treatment in the elderly.

artículo científico publicado en 2002

The biological properties of cetuximab

scientific article published on 03 August 2008

The new era in the treatment of advanced colorectal cancer patients: the role of monoclonal antibodies.

artículo científico publicado en 2006

The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen

artículo científico publicado en 2011

The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen

artículo científico publicado en 2011

The role of bone microenvironment, vitamin D and calcium.

artículo científico publicado en 2012

The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients

artículo científico publicado en 2013

Thymidylate synthase expression in colorectal cancer: the never-ending story

scientific article published on 01 March 2005

Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy.

artículo científico publicado en 2004

Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer.

artículo científico publicado en 2002

Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: A retrospective, multicenter study

artículo científico publicado en 2013

Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer

artículo científico publicado en 2013

Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer

scientific article published on 01 March 2007

Unusual Problems in Breast Cancer and a Rare Lung Cancer Case

artículo científico publicado en 2003

Unusual presentation of Hodgkin's disease mimicking inflammatory bowel disease

scientific article published on 01 July 2001

Updated follow-up of patients treated with bortezomib for relapsed multiple myeloma

artículo científico publicado en 2008

Upper airway study should always come before any sleep study in OSAS evaluation: a giant parapharyngeal lipoma behind OSAS.

artículo científico publicado en 2012

Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma

scientific article published on 21 June 2005

Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

artículo científico publicado en 2006

Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives

artículo científico publicado en 2010

Will trastuzumab change the optimal adjuvant systemic therapy of patients with HER2-positive breast cancer?

artículo científico publicado en 2006

Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma

artículo científico publicado en 2004

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.

artículo científico publicado en 2003

Zoledronic acid in the management of metastatic bone disease.

artículo científico publicado en 2006

Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series

artículo científico publicado en 2009

Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.

artículo científico publicado en 2013

Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.

artículo científico publicado en 2003

Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients

artículo científico publicado en 2005

[Anthracycline cardiotoxicity]

artículo científico publicado en 2003

[The prevention of vomiting due to antineoplastic chemotherapy in the elderly cancer patient]

scientific article published on 01 July 1999

‘If it is not recorded, it has not been done!’? consistency between nursing records and observed nursing care in an Italian hospital

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda